Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

NNEKTAR THERAPEUTICS

EconomyAI buildoutMarket MapFundsWatchlist
Log in
N

NEKTAR THERAPEUTICS

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $10.13M. Net result −$40.62M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $10.13M. Running result $10.13M. Revenue: $10.13M.
  • Research and development (including $1,137 and $613 for the three months ended June 30, 2026 and 2025, respectively, from a related party; and $2,845 and $821 for the six months ended June 30, 2026 and 2025, respectively, from a related party): −$39.13M. Running result −$29M.
  • General and administrative: −$12.77M. Running result −$41.76M.
  • Restructuring and impairment: −$578K. Running result −$42.34M.
  • Operating income: −$42.34M. Running result −$42.34M.
  • Other income: $1.72M. Running result −$40.62M.
  • Pre-tax loss: −$40.62M. Running result −$40.62M.
  • Income tax expense: −$2K. Running result −$40.62M.
  • Net loss: −$40.62M. Running result −$40.62M.